|
TATDN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.79020000010833E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.56420000002799E-06 |
| Normal-vs-Stage2 |
6.636100E-03 |
| Normal-vs-Stage3 |
2.046500E-04 |
| Normal-vs-Stage4 |
5.184100E-03 |
| Stage1-vs-Stage2 |
7.365800E-01 |
| Stage1-vs-Stage3 |
2.586200E-01 |
| Stage1-vs-Stage4 |
1.795790E-01 |
| Stage2-vs-Stage3 |
5.846600E-01 |
| Stage2-vs-Stage4 |
3.395000E-01 |
| Stage3-vs-Stage4 |
5.784800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.39430000001673E-07 |
| Normal-vs-AfricanAmerican |
4.985000E-04 |
| Normal-vs-Asian |
9.501900E-02 |
| Caucasian-vs-AfricanAmerican |
6.973200E-01 |
| Caucasian-vs-Asian |
5.999800E-01 |
| AfricanAmerican-vs-Asian |
5.020800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.2945000040292E-09 |
| Normal-vs-Female |
2.798200E-01 |
| Male-vs-Female |
4.223400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.772430E-04 |
| Normal-vs-Extreme_Weight |
3.95479999970583E-07 |
| Normal-vs-Obese |
4.573500E-04 |
| Normal-vs-Extreme_Obese |
3.407700E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.697200E-01 |
| Normal_Weight-vs-Obese |
3.296000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.490200E-01 |
| Extreme_Weight-vs-Obese |
1.803960E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.156000E-01 |
| Obese-vs-Extreme_Obese |
3.972600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.277200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.642100E-04 |
| Normal-vs-Age(61-80Yrs) |
9.70119999887942E-08 |
| Normal-vs-Age(81-100Yrs) |
8.554100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.486400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.038840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.374100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.197360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.080300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.392000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.191470E-04 |
| Normal-VS-Type2 PRCC |
1.52170054334988E-10 |
| Normal-VS-KIRP CIMP |
6.355800E-01 |
| Normal-VS-Unclassified PRCC |
9.026400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.151670E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.748600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.993000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.262800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.335400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.438000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.44399969548692E-10 |
| Normal-vs-N1 |
4.237800E-04 |
| Normal-vs-N2 |
3.843400E-01 |
| N0-vs-N1 |
3.194000E-01 |
| N0-vs-N2 |
7.004600E-01 |
| N1-vs-N2 |
8.440200E-01 |
|
|
